Souhaitez-vous accéder aux communiqués récents ?

TORONTO, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Media are invited to attend TRREB’s highly anticipated 2026 Market Outlook and Year in Review event on Wednesday, February 4, 2026, at 10:00 a.m. Hear...

VANCOUVER, British Columbia, Jan. 23, 2026 (GLOBE NEWSWIRE) -- via IBN -- Cambridge House International, a leader in producing North America’s largest resource conferences and Canada’s largest...

SCOTTSDALE, Ariz., Jan. 23, 2026 (GLOBE NEWSWIRE) -- onsemi (Nasdaq: ON) plans to announce its financial results for the fourth quarter and full year, which ended December 31, 2025, after market...

The Identity and Access Forum has announced its 2026 Steering Committee.

LAS VEGAS, Jan. 23, 2026 (GLOBE NEWSWIRE) -- While CES 2026 was packed with product launches and first-time reveals, one keyboard that wasn’t new continued to generate discussion. NuPhy’s Kick75,...

NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, announced the agenda for the Digital Asset Virtual Investor Conference...

THE WOODLANDS, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will ring the Nasdaq Stock Market Closing Bell on Tuesday, January...

FORT MYERS, Fla., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that the Company will release financial results for the first quarter ended...

Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and...

WATERTOWN, Mass., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing...